Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GWN 323 |
Trade Name | |
Synonyms | GWN323|GWN-323 |
Drug Descriptions |
GWN 323 is an activating monoclonal antibody that binds to the glucocorticoid-induced tumor necrosis factor receptor, TNFRSF18 (GITR, CD357), resulting in activation of anti-tumor immunity (PMID: 27591414). |
DrugClasses | GITR Antibody 7 |
CAS Registry Number | NA |
NCIT ID | C128028 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GWN 323 | GWN 323 | 0 | 1 |
GWN 323 + Spartalizumab | GWN 323 Spartalizumab | 0 | 1 |